OGN
Price
$9.86
Change
-$0.14 (-1.40%)
Updated
Jun 27 closing price
Capitalization
4.73B
43 days until earnings call
PFE
Price
$24.19
Change
-$0.05 (-0.21%)
Updated
Jun 27 closing price
Capitalization
157.14B
36 days until earnings call
Interact to see
Advertisement

OGN vs PFE

Header iconOGN vs PFE Comparison
Open Charts OGN vs PFEBanner chart's image
Organon & Co
Price$9.86
Change-$0.14 (-1.40%)
Volume$4.46M
Capitalization4.73B
Pfizer
Price$24.19
Change-$0.05 (-0.21%)
Volume$39.53M
Capitalization157.14B
OGN vs PFE Comparison Chart in %
Loading...
OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PFE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OGN vs. PFE commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OGN is a Buy and PFE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (OGN: $9.86 vs. PFE: $24.19)
Brand notoriety: OGN: Not notable vs. PFE: Notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: OGN: 74% vs. PFE: 93%
Market capitalization -- OGN: $4.73B vs. PFE: $157.14B
OGN [@Pharmaceuticals: Major] is valued at $4.73B. PFE’s [@Pharmaceuticals: Major] market capitalization is $157.14B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OGN’s FA Score shows that 2 FA rating(s) are green whilePFE’s FA Score has 1 green FA rating(s).

  • OGN’s FA Score: 2 green, 3 red.
  • PFE’s FA Score: 1 green, 4 red.
According to our system of comparison, OGN is a better buy in the long-term than PFE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OGN’s TA Score shows that 4 TA indicator(s) are bullish while PFE’s TA Score has 4 bullish TA indicator(s).

  • OGN’s TA Score: 4 bullish, 4 bearish.
  • PFE’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, OGN is a better buy in the short-term than PFE.

Price Growth

OGN (@Pharmaceuticals: Major) experienced а +1.13% price change this week, while PFE (@Pharmaceuticals: Major) price change was +0.92% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.72%. For the same industry, the average monthly price growth was +3.48%, and the average quarterly price growth was +7.77%.

Reported Earning Dates

OGN is expected to report earnings on Aug 12, 2025.

PFE is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+0.72% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PFE($157B) has a higher market cap than OGN($4.73B). PFE has higher P/E ratio than OGN: PFE (74.92) vs OGN (4.64). PFE YTD gains are higher at: -5.545 vs. OGN (-32.543). PFE has higher annual earnings (EBITDA): 9.56B vs. OGN (1.44B). PFE has more cash in the bank: 12.7B vs. OGN (693M). OGN has less debt than PFE: OGN (8.76B) vs PFE (70.8B). PFE has higher revenues than OGN: PFE (58.5B) vs OGN (6.26B).
OGNPFEOGN / PFE
Capitalization4.73B157B3%
EBITDA1.44B9.56B15%
Gain YTD-32.543-5.545587%
P/E Ratio4.6474.926%
Revenue6.26B58.5B11%
Total Cash693M12.7B5%
Total Debt8.76B70.8B12%
FUNDAMENTALS RATINGS
PFE: Fundamental Ratings
PFE
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
74
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
OGNPFE
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
50%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
72%
Bearish Trend 4 days ago
60%
Momentum
ODDS (%)
Bearish Trend 4 days ago
63%
Bearish Trend 4 days ago
64%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
53%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
68%
Bullish Trend 4 days ago
57%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
64%
Bullish Trend 4 days ago
50%
Advances
ODDS (%)
Bullish Trend 20 days ago
67%
Bullish Trend 19 days ago
56%
Declines
ODDS (%)
Bearish Trend 18 days ago
73%
Bearish Trend 4 days ago
60%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 4 days ago
60%
Aroon
ODDS (%)
Bullish Trend 4 days ago
49%
Bullish Trend 4 days ago
49%
View a ticker or compare two or three
Interact to see
Advertisement
OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PFE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VWENX77.740.30
+0.39%
Vanguard Wellington™ Admiral™
DFFCX55.130.11
+0.20%
Davis Financial C
JSEZX38.570.02
+0.05%
JPMorgan Small Cap Equity R2
FTVSX33.89N/A
N/A
FullerThaler Behav Md-Cp Val Instl
AMAKX9.89N/A
N/A
American Century Small Cap Dividend R6

OGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGN has been loosely correlated with PFE. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if OGN jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGN
1D Price
Change %
OGN100%
-1.40%
PFE - OGN
44%
Loosely correlated
-0.21%
AMGN - OGN
41%
Loosely correlated
-0.71%
BIIB - OGN
40%
Loosely correlated
-0.66%
LLY - OGN
39%
Loosely correlated
-2.47%
GSK - OGN
38%
Loosely correlated
+0.08%
More

PFE and

Correlation & Price change

A.I.dvisor indicates that over the last year, PFE has been loosely correlated with GSK. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if PFE jumps, then GSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PFE
1D Price
Change %
PFE100%
-0.21%
GSK - PFE
60%
Loosely correlated
+0.08%
AMGN - PFE
58%
Loosely correlated
-0.71%
ABBV - PFE
56%
Loosely correlated
-2.40%
NVS - PFE
55%
Loosely correlated
-0.26%
BMY - PFE
51%
Loosely correlated
-0.64%
More